Lilly’s Blood Cancer Drug Shows Promise in Trial as Early Treatment

Eli Lilly’s approved blood cancer therapy Jaypirca helped delay progression of the disease in previously untreated patients in a late-stage study, advancing it as a…

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/s/viewarticle/lillys-blood-cancer-drug-shows-promise-trial-early-treatment-2025a1000nnm
via IFTTT

Anxiety and Depression More Common in Adolescents With Cancer

As cancer incidence rises in adolescents and young adults, so does concern about their elevated mental health-related symptoms.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/anxiety-and-depression-more-common-adolescents-cancer-2025a1000no5
via IFTTT

Maternal Immunity Drives Cytomegalovirus Transmission Risk in Pregnancy

Mothers with preconception immunity who transmit cytomegalovirus to their fetuses have reduced long-term memory T cells, resembling the immune profile seen in primary cytomegalovirus infection.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/maternal-immunity-drives-cytomegalovirus-transmission-risk-2025a1000nns
via IFTTT

Can Sacubitril-Valsartan Prevent Cardiac Dysfunction Associated With Breast Cancer Therapy?

Sacubitril-valsartan does not significantly attenuate the adjuvant breast cancer therapy-related ejection fraction decline but appears to prevent chronic myocardial injury and stress, a study shows.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/can-sacubitril-valsartan-prevent-cardiac-dysfunction-2025a1000nel
via IFTTT

robotic surgeon, gynecologic cancer treatment center, holistic oncologist

Design a site like this with WordPress.com
Get started